Graceway Pharmaceuticals, LLC (Graceway), headquartered in Bristol, Tennessee, is a specialty pharmaceutical company founded in 2006. The company was founded through the partnership of industry veteran Jefferson J. Gregory and GTCR Golder Rauner, LLC, a leader in the private equity industry for more than 25 years. GTCR manages more than $8 billion in equity with a strategic focus on high-growth industries and significant investment experience in both specialty branded and generic pharmaceutical companies. The acquisition of the 3M pharmaceuticals North and South American business in December 2006 has positioned the company as a leader in the marketing of specialty pharmaceutical products.
Latest:
- Data Demonstrate Zyclara™ (Imiquimod) Cream, 3.75% Greatly Improves Efficacy of Cryosurgery in Reducing Actinic Keratoses (AK) August 6, 2010
- New Data Demonstrate Zyclara™ Imiquimod 3.75% Superior to Placebo for Treatment of External Genital Warts (EGW) July 9, 2010
- Maxair Autohaler Remains Available Through December 31, 2013 April 19, 2010
- FDA Approves Zyclara™ (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses March 29, 2010
- Graceway Announces Journal of the American Academy of Dermatology Publishes Articles on New Short-Course Imiquimod Formulation in Actinic Keratosis March 8, 2010
- Graceway Extends Partnership with NASCAR Camping World Truck Series Driver Aric Almirola; Adds Sprint Cup Series February 12, 2010